Imagine giving a baby animal a single 'super-shot' of beneficial bacteria that acts like a permanent software update for its gut. This update teaches the animal how to turn feed into muscle much more efficiently. Instead of guessing which bacteria work, the team uses a smart computer program to find the perfect bacterial team for specific goals.
Livestock production efficiencies have plateaued, while traditional growth methods like antibiotics and hormones are unsustainable. This leads to increased cropland use, CO2 emissions, and water irrigation requirements to feed a growing population.
A hybrid AI-based Discovery Platform and specific Direct-Fed Microbials (DFM) consisting of multi-strain bacterial consortia.
If you are a commercial broiler producer dealing with plateaued growth rates and high feed costs — this project developed Direct-Fed Microbials (DFMs) that improve the Food Conversion Ratio (FCR). This allows for greater food supply at a lower cost.
If you are a feed additive manufacturer dealing with the need to replace antibiotics with sustainable alternatives — this project developed a Discovery Platform that identifies multi-strain bacterial ecologies. This enables the creation of natural, native growth promoters.
If you are a biotech firm dealing with the slow process of identifying effective gut microbiota — this project developed a hybrid AI-based Discovery Platform. This tool quickly identifies powerful bacterial consortia networks for various species.
The technology aims to improve the Food Conversion Ratio (FCR), which results in a greater food supply at a lower cost. Based on available project data, this is achieved through a single dose administered in early life.
Yes, Aviwell intends to commercialize its Discovery Platform to develop DFMs for other phenotypes and species to provide additional value to the agri-food market.
Based on the work performed report, Aviwell has strengthened its Intellectual Property position and utilizes proprietary biostatistical algorithms within its Discovery Platform.
The project objective explicitly states that EIC funds are needed for market-approval and entry of the DFM products.
The DFMs are designed to be fed as a single dose in the early life of the animal to alter the trajectory of gut microbiome development.
The project is led by a single French SME (CENTRE DE RECHERCHE ET DE DEVELOPPEMENT DES ANATIDES DU COURTALET), resulting in a 100% industry ratio. This lean structure suggests a highly focused commercial drive, though the coordinator is currently leveraging external partnerships with research institutions to strengthen IP and technical validation.
Contact the Centre de Recherche et Développement des Anatides du Courtalet in France
Contact us to explore licensing opportunities for the AI Discovery Platform.
